Asanuma H, Fujita N, Kato S, Kawashima Y, et al. Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study. Prostate 2026 May 26. doi: 10.1002/pros.70203.
PMID: 42190045